Protein Turnover Atlas™

These products are of broad relevance to those involved in drug discovery and development efforts, providing significant benefit to researchers seeking to evaluate novel targets and modalities. In particular, the Atlas products can benefit teams working to develop emerging therapeutic modalities, such as targeted protein degraders, molecular glues, RNA-targeting drugs, and covalent therapeutics. By using data from the Atlas products to guide preclinical research, scientists can make informed predictions about the safety and efficacy of a particular therapeutic approach early in the drug development process, saving considerable time and expense. The Atlas products also have substantial utility for data science and biological intelligence teams, as large amounts of high-quality data are required for the training and development of novel models and tools.

Momentum's Atlas products facilitate the development and training of novel computational models and other tools by data science teams seeking to leverage biological data; as these models are only as accurate as the data used in their development, the provision of high-quality, curated data through the Atlas products supports the creation of superior data science products. The information provided in the Atlas products is well-curated and easily accessible, including both HTML reports and tabular data formats, with high proteome coverage across all analyzed cell and tissue types.